361 Capital’s Balchem Corp BCPC Stock Holding History

361 Capital’s Portfolio BCPC Stock Details BCPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-29,951	Closed	-$2.99M	–	391
2019 Q2	$2.99M	Sell	29,951 -2,002	-6%	-$195K	0.53%	31
2019 Q1	$2.96M	Buy	+31,953	New	+$2.76M	0.51%	52

Other funds holding BCPC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

361 Capital's BCPC Position: Q3 2019 in Review

361 Capital sold out of Balchem Corp (BCPC) in Q3 2019, closing a stake of 29,951 shares — an estimated $2.99M sold.

361 Capital first reported a position in BCPC in Q1 2019 and held it in 2 quarters. The position peaked at $2.99M in Q2 2019. 228 funds tracked by Wall St. Rank hold BCPC as of Q3 2019.

361 Capital reported no remaining Balchem Corp position as of Q3 2019 after selling out during the quarter.
361 Capital sold 29,951 Balchem Corp shares in Q3 2019, an estimated $2.99M.
361 Capital first reported a position in Balchem Corp in Q1 2019 and held it in 2 quarters.
361 Capital's Balchem Corp position peaked at $2.99M in Q2 2019.
228 funds tracked by Wall St. Rank held Balchem Corp as of Q3 2019.

Based on 361 Capital's 13F filing for Q3 2019, filed 14 Nov 2019.